Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017

OBJECTIVE: Chinese patent medicine (CPM) has been widely used to treat eczema in mainland China for decades. This study aims to investigate circulating CPM for eczema in mainland China and to evaluate the reporting quality of randomized controlled trials (RCTs) of them by using the CONSORT-CHM formu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Zhou, Boyang, Zhou, Lihong, Li, Linfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512083/
https://www.ncbi.nlm.nih.gov/pubmed/33014102
http://dx.doi.org/10.1155/2020/2949125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512083/
https://www.ncbi.nlm.nih.gov/pubmed/33014102
http://dx.doi.org/10.1155/2020/2949125

Ejemplares similares